Kmagic DT Tablet contains Ketorolac 10mg, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the short-term management of moderate to severe acute pain. Ketorolac exerts its analgesic and anti-inflammatory effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the synthesis of prostaglandins involved in pain and inflammation. Kmagic DT is formulated as a dispersible tablet, allowing rapid dissolution and absorption, which facilitates prompt onset of analgesia. It is commonly prescribed for postoperative pain, musculoskeletal injuries, and other conditions requiring potent analgesia where opioid use is to be minimized. The recommended dosage should not exceed 40mg per day, and treatment duration is generally limited to 5 days due to risks of gastrointestinal, renal, and cardiovascular adverse effects. Kmagic DT is contraindicated in patients with active peptic ulcer disease, recent gastrointestinal bleeding, advanced renal impairment, or hypersensitivity to NSAIDs. Caution is advised in patients with cardiovascular disease, asthma, or those on concomitant anticoagulant therapy. Common adverse reactions include gastrointestinal discomfort, nausea, dizziness, and headache. Patients should be monitored for signs of bleeding, renal dysfunction, or hypersensitivity reactions during therapy. Kmagic DT should be used under medical supervision with adherence to prescribed dosing guidelines.